11-2670241-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000597346.1(KCNQ1OT1):​n.29754T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.597 in 398,376 control chromosomes in the GnomAD database, including 74,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 31027 hom., cov: 32)
Exomes 𝑓: 0.58 ( 43238 hom. )

Consequence

KCNQ1OT1
ENST00000597346.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.707

Publications

178 publications found
Variant links:
Genes affected
KCNQ1OT1 (HGNC:6295): (KCNQ1 opposite strand/antisense transcript 1) Human chromosomal region 11p15.5 contains two clusters of epigenetically-regulated genes that are expressed from only one chromosome in a parent-of-origin manner. Each cluster, or imprinted domain, is regulated by a functionally independent imprinting control region (ICR). The human CDKN1C/KCNQ1OT1 domain is regulated by an ICR located in an intron of KCNQ1, and contains at least eight genes that are expressed exclusively or preferentially from the maternally-inherited allele. The DNA of the ICR is specifically methylated on the maternally-inherited chromosome, and unmethylated on the paternally-inherited chromosome. The ICR contains the promoter of the KCNQ1OT1 gene that is exclusively expressed from the paternal allele. The KCNQ1OT1 transcript is the antisense to the KCNQ1 gene and is a unspliced long non-coding RNA. It interacts with chromatin and regulates transcription of multiple target genes through epigenetic modifications. The transcript is abnormally expressed from both chromosomes in most patients with Beckwith-Wiedemann syndrome, and the transcript also plays an important role in colorectal carcinogenesis. [provided by RefSeq, Apr 2012]
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 11-2670241-A-G is Benign according to our data. Variant chr11-2670241-A-G is described in ClinVar as Benign. ClinVar VariationId is 1256894.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.874 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000597346.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1OT1
NR_002728.4
MANE Select
n.29754T>C
non_coding_transcript_exon
Exon 1 of 1
KCNQ1
NM_000218.3
MANE Select
c.1514+8160A>G
intron
N/ANP_000209.2
KCNQ1
NM_001406836.1
c.1418+8160A>G
intron
N/ANP_001393765.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1OT1
ENST00000597346.1
TSL:6 MANE Select
n.29754T>C
non_coding_transcript_exon
Exon 1 of 1
KCNQ1
ENST00000155840.12
TSL:1 MANE Select
c.1514+8160A>G
intron
N/AENSP00000155840.2
KCNQ1
ENST00000335475.6
TSL:1
c.1133+8160A>G
intron
N/AENSP00000334497.5

Frequencies

GnomAD3 genomes
AF:
0.625
AC:
94954
AN:
151936
Hom.:
30982
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.782
Gnomad AMI
AF:
0.417
Gnomad AMR
AF:
0.649
Gnomad ASJ
AF:
0.634
Gnomad EAS
AF:
0.895
Gnomad SAS
AF:
0.750
Gnomad FIN
AF:
0.514
Gnomad MID
AF:
0.551
Gnomad NFE
AF:
0.515
Gnomad OTH
AF:
0.618
GnomAD4 exome
AF:
0.579
AC:
142692
AN:
246322
Hom.:
43238
Cov.:
0
AF XY:
0.577
AC XY:
72040
AN XY:
124814
show subpopulations
African (AFR)
AF:
0.773
AC:
5549
AN:
7182
American (AMR)
AF:
0.670
AC:
4981
AN:
7434
Ashkenazi Jewish (ASJ)
AF:
0.626
AC:
5788
AN:
9240
East Asian (EAS)
AF:
0.901
AC:
20624
AN:
22894
South Asian (SAS)
AF:
0.763
AC:
2307
AN:
3024
European-Finnish (FIN)
AF:
0.508
AC:
10578
AN:
20824
Middle Eastern (MID)
AF:
0.600
AC:
777
AN:
1294
European-Non Finnish (NFE)
AF:
0.520
AC:
82185
AN:
158054
Other (OTH)
AF:
0.605
AC:
9903
AN:
16376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
4212
8424
12635
16847
21059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
374
748
1122
1496
1870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.625
AC:
95063
AN:
152054
Hom.:
31027
Cov.:
32
AF XY:
0.630
AC XY:
46815
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.782
AC:
32431
AN:
41472
American (AMR)
AF:
0.649
AC:
9921
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.634
AC:
2199
AN:
3466
East Asian (EAS)
AF:
0.895
AC:
4626
AN:
5168
South Asian (SAS)
AF:
0.751
AC:
3615
AN:
4816
European-Finnish (FIN)
AF:
0.514
AC:
5438
AN:
10574
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.515
AC:
34984
AN:
67960
Other (OTH)
AF:
0.621
AC:
1309
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1739
3478
5217
6956
8695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.564
Hom.:
80282
Bravo
AF:
0.644
Asia WGS
AF:
0.793
AC:
2757
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 24, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26911676)

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

KCNQ1-related disorder Benign:1
Dec 03, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.072
DANN
Benign
0.53
PhyloP100
-0.71
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs231362; hg19: chr11-2691471; API